全文获取类型
收费全文 | 1166篇 |
免费 | 69篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 42篇 |
妇产科学 | 17篇 |
基础医学 | 142篇 |
口腔科学 | 29篇 |
临床医学 | 111篇 |
内科学 | 275篇 |
皮肤病学 | 16篇 |
神经病学 | 138篇 |
特种医学 | 16篇 |
外科学 | 169篇 |
综合类 | 1篇 |
预防医学 | 74篇 |
眼科学 | 5篇 |
药学 | 76篇 |
中国医学 | 2篇 |
肿瘤学 | 122篇 |
出版年
2023年 | 5篇 |
2022年 | 10篇 |
2021年 | 27篇 |
2020年 | 17篇 |
2019年 | 24篇 |
2018年 | 20篇 |
2017年 | 26篇 |
2016年 | 16篇 |
2015年 | 23篇 |
2014年 | 37篇 |
2013年 | 59篇 |
2012年 | 88篇 |
2011年 | 88篇 |
2010年 | 38篇 |
2009年 | 44篇 |
2008年 | 76篇 |
2007年 | 75篇 |
2006年 | 88篇 |
2005年 | 68篇 |
2004年 | 81篇 |
2003年 | 60篇 |
2002年 | 70篇 |
2001年 | 15篇 |
2000年 | 11篇 |
1999年 | 12篇 |
1998年 | 12篇 |
1997年 | 8篇 |
1996年 | 9篇 |
1995年 | 12篇 |
1994年 | 7篇 |
1993年 | 6篇 |
1992年 | 15篇 |
1991年 | 12篇 |
1990年 | 11篇 |
1989年 | 6篇 |
1988年 | 9篇 |
1987年 | 8篇 |
1986年 | 3篇 |
1985年 | 6篇 |
1984年 | 6篇 |
1983年 | 8篇 |
1982年 | 3篇 |
1981年 | 3篇 |
1978年 | 3篇 |
1976年 | 2篇 |
1969年 | 3篇 |
1968年 | 2篇 |
1966年 | 1篇 |
1939年 | 1篇 |
1937年 | 2篇 |
排序方式: 共有1244条查询结果,搜索用时 15 毫秒
61.
Edna Aparecida Ferraz de Araújo Navas Aline Cássia Inocêncio Janete Dias Almeida Graziella Nuernberg Back-Brito Adolfo José Mota Antonio Olavo Cardoso Jorge Silvia Maria Rodrigues Querido Ivan Balducci Cristiane Yumi Koga-Ito 《Journal of oral pathology & medicine》2009,38(10):764-767
Objective: The aim of this study was to evaluate the prevalence of Candida spp. and presence of oral lesions in Brazilian leprosy patients under multidrug therapy (MDT).
Methods: Thirty-eight individuals (18 males and 20 females, median age 53 years) clinically and microbiologically diagnosed as leprosy (lepromatous variant), and under MDT for at least 45 days were studied. The control group constituted by 38 healthy individuals (median age 53.5), matched to the test group in relation to age, gender and oral conditions. Oral rinses were collected and the Candida identification was performed by phenotypic tests. The existence of Candida dubliniensis among the isolates was analyzed using a validated multiplex PCR assay. Twenty-nine leprosy patients were examined intra-orally for the presence of lesions. Data were analyzed by z- and Mann–Whitney tests (α = 5%).
Results: Yeast carriage rate between leprosy patients (65.8%) and controls (47.4%) was similar ( P = 0.099), and no significant difference between yeast counts was observed ( P = 0.1004). Candida albicans was the most frequently isolated species in both groups. In the leprosy group, Candida tropicalis and Candida parapsilosis were also identified. In the control group, we additionally identified Candida tropicalis , Candida glabrata and Candida kefyr. Candida dubliniensis was not detected. No leprosy-related oral lesion was registered.
Conclusion: Within the limits of the study, we concluded that Brazilian leprosy patients under MDT showed similar levels of carriage and Candida species distribution in relation to the controls. 相似文献
Methods: Thirty-eight individuals (18 males and 20 females, median age 53 years) clinically and microbiologically diagnosed as leprosy (lepromatous variant), and under MDT for at least 45 days were studied. The control group constituted by 38 healthy individuals (median age 53.5), matched to the test group in relation to age, gender and oral conditions. Oral rinses were collected and the Candida identification was performed by phenotypic tests. The existence of Candida dubliniensis among the isolates was analyzed using a validated multiplex PCR assay. Twenty-nine leprosy patients were examined intra-orally for the presence of lesions. Data were analyzed by z- and Mann–Whitney tests (α = 5%).
Results: Yeast carriage rate between leprosy patients (65.8%) and controls (47.4%) was similar ( P = 0.099), and no significant difference between yeast counts was observed ( P = 0.1004). Candida albicans was the most frequently isolated species in both groups. In the leprosy group, Candida tropicalis and Candida parapsilosis were also identified. In the control group, we additionally identified Candida tropicalis , Candida glabrata and Candida kefyr. Candida dubliniensis was not detected. No leprosy-related oral lesion was registered.
Conclusion: Within the limits of the study, we concluded that Brazilian leprosy patients under MDT showed similar levels of carriage and Candida species distribution in relation to the controls. 相似文献
62.
63.
64.
65.
66.
Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation 总被引:3,自引:0,他引:3
Messina C Locatelli F Lanino E Uderzo C Zacchello G Cesaro S Pillon M Perotti C Del Fante C Faraci M Rivabella L Calore E De Stefano P Zecca M Giorgiani G Brugiolo A Balduzzi A Dini G Zanesco L Dall'Amico R 《British journal of haematology》2003,122(1):118-127
This study aimed to ascertain whether extracorporeal photochemotherapy (ECP) is an effective treatment for paediatric patients with refractory graft-versus-host disease (GVHD). From January 1992 to December 2000, 77 children (median age 8.6 years) with either acute (n = 33) or chronic (n = 44) GVHD, resistant to conventional immunosuppressive therapy, were treated with ECP in four Italian paediatric hospitals. After ECP, acute GVHD involving skin, liver and gut responded completely in 76%, 60% and 75% of patients respectively. The 5-year overall survival was 69% for responding patients vs 12% for non-responders (P = 0.001). Among the 44 children with chronic GVHD, 15 (44%) showed a complete response and 10 (29%) a significant improvement after ECP. The 5-year overall survival was 96% for responders vs 58% for non-responders (P = 0.04). Our results suggest that ECP is an effective treatment that may be useful in paediatric patients with either acute or chronic GVHD who have failed to respond to standard immunosuppressive therapy. 相似文献
67.
Villa E Moneta A Donatelli F 《The Journal of thoracic and cardiovascular surgery》2002,124(1):210-1; author reply 211
68.
69.
Mariotti S Teloni R von Hunolstein C Romagnoli G Orefici G Nisini R 《Vaccine》2002,20(17-18):2229-2239
Most vaccines are delivered by injection. Mucosal vaccination would increase compliance and decrease the risk of spread of infectious diseases due to a reduction of mucosal colonization and of contaminated syringes. However, most vaccines are unable to induce immune responses when administered mucosally, and require the use of strong adjuvant or effective delivery systems. Synthetic oligodeoxynucleotides (ODN) containing CpG immunostimulatory sequences (ISS) have been shown to act as potent adjuvants of type-1 immune responses also when mucosally co-administered with protein or peptide vaccines. We have shown that ISS can increase the anti-polysaccharide polyribosyl ribitol phosphate (PRP) antibody titres and anti-diphtheria toxin neutralizing antibody, if used as adjuvant of anti-Haemophilus influenzae type b (Hib) PRP vaccine conjugated with cross-reacting material (CRM) of diphtheria toxin in mice. Here, we show that ISS have the potential to increase host local and systemic antibody response against both the PRP and the protein component of a conjugated vaccine when mucosally administered in mice. Mucosal administration of Hib-CRM vaccine induced anti-PRP and neutralizing anti-diphtheria toxin antibodies of all the IgG subclasses, with a predominance of type-1 immune response-associated IgG2a and IgG3. At odds with systemic administration, the mucosal delivery of Hib-CRM induced anti-PRP and anti-diphtheria toxin mucosal IgA. These data envisage the feasibility of a mucosal vaccination with an already licensed Hib-CRM vaccine to achieve both an anti-H. influenzae and -diphtheria effective protection. 相似文献
70.
Intralesional topotecan in advanced ovarian cancer: a clinical report,based on a preclinical study 总被引:2,自引:0,他引:2
Nicoletto MO Padrini R Palumbo M Ziade A Ragazzi RS Pratesi G Artioli G De Cesare M Zunino F 《Oncology reports》2002,9(6):1351-1354
The aim of this study was to evaluate the response of ovarian cancer to intralesionally administered topotecan. Preliminary experiments were carried out in nude mice subcutaneously grafted with three different human ovarian carcinoma cells (A2780, IGROV/DDP and SKOV-3). Topotecan was administered intravenously (i.v.: 10-15 mg/kg every 4th day for 4 times) or intralesionally (i.t.: single dose of 15-20 mg/kg) and tumor size changes/drug toxicity were evaluated. The results indicate that the sensitivity of the three tumor models was different (rank: A2780 > IGROV/DDP > SKOV-3) but, for each tumor line, the pattern of response was similar after i.v. and i.t. administration. No local toxicity was detected, but appreciable systemic toxicity (animal death rate) was observed in spite of the use of a single i.t. dose. The effects of intralesional topotecan administration were then assessed in a patient with an advanced, epithelial ovarian tumor (endometroid type, poorly differentiated histologic grade), already treated with cisplatin and paclitaxel. The treatment (7.5 mg/m(2)) was repeated three times and, although drug plasma levels were in the range generally reported following i.v. administration and typical systemic toxicity occurred, no tumor regression was observed and the patient died 14 months later. We conclude that the intralesional drug delivery is effective to achieve a rapid tumor shrinkage in large tumor lesions, but in the presence of drug resistance, either intrinsic or acquired, intratumor drug administration can not be recommended. 相似文献